We found 2 drugmaker programs for Systemic Mastocytosis medicines and 1 charity fund (1 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Systemic Mastocytosis depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Insurance premiums and treatment-related copays, deductibles and coinsurance. Up to $4,000 a year.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
YourBlueprint Co-Pay Assistance Program: eligible patients with commercial insurance may pay as little as $0 a month; it covers copays, coinsurance and deductibles. Terms and conditions apply.
Patient Assistance Program: Ayvakit at no cost for eligible people who have no insurance, limited insurance or unaffordable out-of-pocket costs, live in the US or a US territory, have a valid prescription and meet financial criteria.
Temporary treatment help: a no-cost supply may be available to eligible patients during a delay or gap in coverage.
YourBlueprint offers one-on-one support with insurance and financial assistance. Call 1-888-258-7768.
Blueprint says Ayvakit is covered by 98% of commercial plans and 99% of Medicare plans, as of February 2026. Blueprint Medicines is now a Sanofi company.
Novartis Oncology Universal Co-Pay Program: for patients with private insurance, with a combined annual limit up to $15,000. Not valid with Medicare, Medicaid, TRICARE, VA, DoD or other federal or state programs.
Novartis lists Rydapt capsules among its products with co-pay programs. The program's per-fill amount for Rydapt is not shown on Novartis's pages, and a free-drug option is not listed here until confirmed on Novartis's own pages.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 2 drugmaker programs for Systemic Mastocytosis medicines and 1 charity fund, 1 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Systemic Mastocytosis, 1 charity fund on this page accepts Medicare (1 open at our last check), and 0 drugmaker free medicine programs name Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
At our last check, Blood Cancer United's Acute Myeloid Leukemia Co-Pay Fund (covered diagnoses include Mastocytosis) fund was open to new applicants. Funds open and close as donations come in, so check the foundation's page before you apply.
Of the drugmaker programs for Systemic Mastocytosis medicines, 1 offers free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (Blood Cancer United) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
